Smt Jadhavbai Nathamal Singhvee Glaucoma Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Department of Uvea, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Indian J Ophthalmol. 2022 Dec;70(12):4218-4225. doi: 10.4103/ijo.IJO_1475_22.
To compare outcomes of surgical management of uveitic glaucoma (UG) and steroid-induced glaucoma (SIG) in children in terms of intraocular pressure (IOP) control, visual acuity, and associations for failure.
This was a retrospective case-control study of consecutive UG (cases) and non-uveitic SIG (controls) in children <18 years of age who underwent surgery between January 2005 and December 2017.
Primary trabeculectomy with mitomycin C (MMC) was performed in 12 cases (mean age: 9.2 ± 4.3 years) and 40 controls (mean age: 10.4 ± 3.7 years) (P = 0.33). Primary phaco-trabeculectomy with MMC was performed in 11 cases (mean age: 11.4 ± 4.7 years) and 16 controls (mean age: 10.4 ± 3.4 years) (P = 0.57). IOP control (P = 0.26), visual acuity (P = 0.97), number of glaucoma medications (P = 0.06), and survival rates (49% cases vs. 68% controls at 5 years; P = 0.22) were similar between the two groups following trabeculectomy. Survival rates in the phaco-trabeculectomy group at 5 years were 68% cases vs. 69% controls (P = 0.71). IOP was higher (P = 0.008) and visual acuity was worse (P = 0.02) in cases at the last visit. Associations for failure (univariate analysis) were younger age (OR: 6.29, 95% CL: 1.43, 27.67; P = 0.03) and male gender (OR: 4.79, 95% CL: 1.09, 20.97; P = 0.04). On multivariate analysis, younger age (OR: 11.985, 95% CL: 1.071, 134.153; P = 0.04) remained significant. Preoperative number of uveitic attacks was protective on univariate (OR: 0.75, 95% CL: 0.48, 1.15; P = 0.1) and multivariate analyses (OR: 0.49, 95% CL: 0.24, 0.09; P = 0.04).
Outcomes of trabeculectomy between cases and controls were similar in our series. However, phaco-trabeculectomy in pediatric uveitic eye group fared worse than eyes with SIG.
比较儿童葡萄膜炎性青光眼(UG)和类固醇诱导性青光眼(SIG)手术治疗的眼压(IOP)控制、视力和失败相关因素。
这是一项回顾性病例对照研究,纳入了 2005 年 1 月至 2017 年 12 月期间接受手术治疗的年龄<18 岁的 UG(病例)和非葡萄膜炎性 SIG(对照组)儿童。
12 例(平均年龄:9.2±4.3 岁)和 40 例(平均年龄:10.4±3.7 岁)(P=0.33)接受了原发性小梁切除术联合丝裂霉素 C(MMC),11 例(平均年龄:11.4±4.7 岁)和 16 例(平均年龄:10.4±3.4 岁)(P=0.57)接受了原发性超声乳化联合小梁切除术联合 MMC。小梁切除术后两组 IOP 控制(P=0.26)、视力(P=0.97)、青光眼药物数量(P=0.06)和生存率(5 年时分别为 49%病例和 68%对照组;P=0.22)相似。5 年时,超声乳化联合小梁切除术组的生存率为 68%病例和 69%对照组(P=0.71)。最后一次就诊时,病例组的 IOP 更高(P=0.008),视力更差(P=0.02)。失败的相关因素(单因素分析)为年龄较小(OR:6.29,95%CL:1.43,27.67;P=0.03)和男性(OR:4.79,95%CL:1.09,20.97;P=0.04)。多因素分析时,年龄较小(OR:11.985,95%CL:1.071,134.153;P=0.04)仍然显著。术前葡萄膜炎发作次数在单因素(OR:0.75,95%CL:0.48,1.15;P=0.1)和多因素分析(OR:0.49,95%CL:0.24,0.09;P=0.04)中均有保护作用。
在我们的研究中,病例组和对照组的小梁切除术结果相似。然而,在儿童葡萄膜炎眼组中,超声乳化联合小梁切除术的效果不如 SIG 眼。